We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

LIMS and ELNs – News and Features

Why Automation Will be the Cornerstone of the Post-COVID Biology Lab content piece image
Industry Insight

Why Automation Will be the Cornerstone of the Post-COVID Biology Lab

With the advent of new technologies like automation and machine/deep learning, biology is becoming a less inferential and more data-driven discipline. Is it time to re-examine the future role of automation in biological research?
Industry Insight

Exploring the Future of Lab Informatics Tools

Lab-based informatics systems, such as LIMS and ELNs, are becoming more commonly used in labs. We spoke with Jeff Carter, co-founder and COO of lab software company Arxspan, to discover how COVID-19 has helped drive digitization and how tools are developing to become more flexible and connected.
What Are the Benefits of Cloud Technology for Life Science Firms? content piece image
Article

What Are the Benefits of Cloud Technology for Life Science Firms?

The inescapable fact for modern businesses is that data is now the backbone of every organisation. In this article, IDBS's Abhay Kini discusses how cloud technology helping life science firms with data reproducibility, sharing, collation and storage across drug development.
From Genome Engineering to COVID-19 Diagnostic Testing at IGI content piece image
Industry Insight

From Genome Engineering to COVID-19 Diagnostic Testing at IGI

The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.
Industry Insight

Asset Monitoring in the Life Sciences: Do Labs Need To Keep a Closer Eye on Their Instruments?

In the day-to-day of research science, the acquisition of a new piece of equipment is a momentous occasion, but one that could see costs and inefficiencies spiral unless labs keep a close eye on their new kit. Asset monitoring software could lend a hand. We spoke to Agilent's Marc Boreham to find out more.
Person pointing a finger at on option on an automated screen.
Article

Three Reasons Why Automation Can Benefit Your Laboratory

In this article, we explore how automation in the laboratory environment can give the scientist greater control over their instruments to drive up standards and quicken the experimental process.
Article

Biobanking Evolution Enabled by Cloud-based Technology

Biobanks are rich collections of data and biospecimens, specifically developed as resources for research. Cloud-based laboratory information management systems (LIMS) are emerging as a better way to store, analyze and share biospecimens, offering an opportunity for biobanks looking to invest in effective data management solutions to support these interrelated goals.
Article

How Could a Focus on User Experience Build Better Labs?

Companies undergoing digital transformation are beginning to realise that just implementing new software isn’t valuable unless researchers can make the most of it. In this article, Paula de Matos, a consultant at The Pistoia Alliance, outlines five technologies that will drive the development of user experience in healthcare and the life sciences in the next few years.
News

CloudLIMS Offers Free LIMS to SARS-CoV-2 and COVID-19 Research and Testing Laboratories

CloudLIMS is making its "in the cloud" LIMS free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.
Article

Zantac Recalls Highlight the Need To Screen and Quantify Impurities With Confidence

We tend to take for granted the quality and safety of our most used medicines, but recently, potentially carcinogenic nitrosamine impurities were found in commercially available drugs. This discovery, and the measures taken to quickly mitigate any risks, highlight the role of advancing analytical technology in safeguarding consumer health.
Advertisement